NOISEReport
Coverage history

Assembled by NOISE.

Report / Business

Published by NOISE

Moderna shares plunge on leaked cancer vaccine data despite positive results

From Evening NOISE.

Moderna shares fell as much as 25% on Thursday after partial data on its experimental cancer vaccine with Merck leaked ahead of the full release. The complete results, published later that day, showed the vaccine plus Keytruda cut the risk of recurrence or death by 42% in certain melanoma patients versus Keytruda alone, and reduced the risk of distant spread or death by 38%. Analysts said the share decline reflected elevated investor expectations rather than disappointing efficacy. The vaccine is personalized and is also being studied in lung, bladder, and kidney cancers.

Saved versions

These dates record changes to NOISE’s copy. They are not event dates.

  1. Retained copyCurrentIn saved edition